Exercise and Nutritional Supplementation
ENSASL
1 other identifier
interventional
45
1 country
1
Brief Summary
To understand the effects of a novel dietary supplement when used in conjunction with a healthy lifestyle exercise program and to define biomarkers that are specific to sarcopenia. A primary aim in the present study is to determine whether a relationship exists between positive changes in body composition through increases in lean mass and reductions in body fat following oral supplementation of naturally occurring food components in combination with exercise. The purpose of the present study is to examine the effects of a multi-nutrient supplement in combination with an endurance and resistance based exercise intervention in a cohort of older adult men with varying degrees of sarcopenia as compared to younger male controls (McMaster/CIHR/Exerkine project). A sub-purpose nested within the study is to provide serum and muscle samples for use in an aging/sarcopenia biomarker discovery study taken at pre-intervention for the young and older men (Buck Institute/Astellas project).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 10, 2018
CompletedFirst Posted
Study publicly available on registry
May 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2019
CompletedMay 16, 2023
May 1, 2023
1 year
May 10, 2018
May 12, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Body Composition
Fat-Free and Fat Mass
12 weeks
Muscle Strength
Knee extension isometric strength and leg press
12 weeks
Functional Outcomes
6 Minute Walk Test
12 weeks
Secondary Outcomes (6)
Mitochondrial Function
12 weeks
Muscle Fibre Size
12 weeks
Inflammatory markers
12 weeks
Quality of Life assessment
12 weeks
Glycemia measurements
12 weeks
- +1 more secondary outcomes
Study Arms (4)
Multinutrient Supplement
ACTIVE COMPARATORParticipants will be allocated in a randomized double-masked manner to receive a multi-nutrient supplement (protein and creatine sachet and omega-3 oil) or placebo during a 12 week home-based exercise program and we will assess the influence on the primary and secondary outcomes.
Age biological and chronological
NO INTERVENTIONThe primary and secondary outcomes will be compared between the younger and older age groups as a function of both exercise and nutritional supplementation.
Sarcopenia grades
NO INTERVENTIONThe baseline primary and secondary outcomes will be compared for each of the 3 older adults males groups as a function of muscle mass (healthy active, mild sarcopenia and moderate sarcopenia).
Exercise - home based programme
EXPERIMENTALEach of the older participants will undergo a 12 week home-based exercise program (endurance = increased steps; resistance = body weight and elastic band exercise) to determine the effects on the primary and secondary outcomes.
Interventions
Compare the effects of a multi-nutrient supplement following a healthy lifestyles program in healthy young men and women, healthy older men, and sarcopenic older men.
We will evaluate the effect of 12 weeks of combined endurance and resistance home-based exercise in younger and older adults.
Eligibility Criteria
You may qualify if:
- Inactive younger men (\< 1 hour of formal exercise/week) in the overweight BMI category (25 - 29.9 kg/m2).
- Healthy older male participants will have a body mass index \< 30 kg/m2, muscle mass index \> 7.23 kg/m2, and a 4-meter walk test \> 0.8 m/s.
- Men in the older adult "sarcopenia" group will be individuals that have a body mass index \< 30 kg/m2, a muscle mass index between 8.51-10.75 kg/m2, and a 4-meter walk test \< 0.8m/s.
You may not qualify if:
- Current smokers
- On more than one anti-diabetic drug
- Cardiovascular disease (myocardial infarction and/or hypertension requiring more than 2 medications)
- Congestive heart failure
- Renal disease (creatinine \> 130)
- Previous stroke
- Hypertension requiring more than two-pharmacological agents
- Active musculoskeletal injuries and/or severe osteoarthritis
- Significant weight loss in the 3-month period prior to the study
- Vegan diet
- Dairy protein allergy
- History of muscle and/or bone wasting diseases
- Concurrent medications known to affect protein metabolism (i.e. corticosteroids, or prescription strength acne medications)
- Inability to consent
- Chronic obstructive pulmonary disease (FVC or FEV1 \< 80% of age predicted mean value or requiring any medication other than a puffer as needed)
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McMaster University Medical Center
Hamilton, Ontario, L8N 3Z5, Canada
Related Publications (7)
Brose A, Parise G, Tarnopolsky MA. Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. J Gerontol A Biol Sci Med Sci. 2003 Jan;58(1):11-9. doi: 10.1093/gerona/58.1.b11.
PMID: 12560406RESULTTarnopolsky M, Zimmer A, Paikin J, Safdar A, Aboud A, Pearce E, Roy B, Doherty T. Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults. PLoS One. 2007 Oct 3;2(10):e991. doi: 10.1371/journal.pone.0000991.
PMID: 17912368RESULTBell KE, Snijders T, Zulyniak M, Kumbhare D, Parise G, Chabowski A, Phillips SM. A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial. PLoS One. 2017 Jul 18;12(7):e0181387. doi: 10.1371/journal.pone.0181387. eCollection 2017.
PMID: 28719669RESULTMurphy CH, Saddler NI, Devries MC, McGlory C, Baker SK, Phillips SM. Leucine supplementation enhances integrative myofibrillar protein synthesis in free-living older men consuming lower- and higher-protein diets: a parallel-group crossover study. Am J Clin Nutr. 2016 Dec;104(6):1594-1606. doi: 10.3945/ajcn.116.136424. Epub 2016 Nov 9.
PMID: 27935521RESULTChurchward-Venne TA, Breen L, Di Donato DM, Hector AJ, Mitchell CJ, Moore DR, Stellingwerff T, Breuille D, Offord EA, Baker SK, Phillips SM. Leucine supplementation of a low-protein mixed macronutrient beverage enhances myofibrillar protein synthesis in young men: a double-blind, randomized trial. Am J Clin Nutr. 2014 Feb;99(2):276-86. doi: 10.3945/ajcn.113.068775. Epub 2013 Nov 27.
PMID: 24284442RESULTNilsson MI, Mikhail A, Lan L, Di Carlo A, Hamilton B, Barnard K, Hettinga BP, Hatcher E, Tarnopolsky MG, Nederveen JP, Bujak AL, May L, Tarnopolsky MA. A Five-Ingredient Nutritional Supplement and Home-Based Resistance Exercise Improve Lean Mass and Strength in Free-Living Elderly. Nutrients. 2020 Aug 10;12(8):2391. doi: 10.3390/nu12082391.
PMID: 32785021RESULTPerez K, Ciotlos S, McGirr J, Limbad C, Doi R, Nederveen JP, Nilsson MI, Winer DA, Evans W, Tarnopolsky M, Campisi J, Melov S. Single nuclei profiling identifies cell specific markers of skeletal muscle aging, frailty, and senescence. Aging (Albany NY). 2022 Dec 13;14(23):9393-9422. doi: 10.18632/aging.204435. Epub 2022 Dec 13.
PMID: 36516485RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Tarnopololsky, MD/PhD
McMaster University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The nutritional supplement will be delivered to a 3rd party contract research organization and the allocation will only be un-blinded after data lock.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Professor, Director of Neuromuscular and Neurometabolic Clinic
Study Record Dates
First Submitted
May 10, 2018
First Posted
May 25, 2018
Study Start
May 1, 2018
Primary Completion
May 1, 2019
Study Completion
May 1, 2019
Last Updated
May 16, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share